BIONIK LABORATORIES CORP. Operating Income
BIONIK LABORATORIES CORP. reported Operating Income of -$4.83 million for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-06-21
- BIONIK LABORATORIES CORP. operating income (loss) for the quarter ending 2023-03-31 was -$1.30M.
- BIONIK LABORATORIES CORP. operating income (loss) for the quarter ending 2022-12-31 was -$1.04M.
- BIONIK LABORATORIES CORP. operating income (loss) for the quarter ending 2022-09-30 was -$1.11M.
- BIONIK LABORATORIES CORP. operating income (loss) for the quarter ending 2022-06-30 was -$1.37M.
- BIONIK LABORATORIES CORP. operating income (loss) for fiscal 2023 was -$4.83M.
- BIONIK LABORATORIES CORP. operating income (loss) for fiscal 2022 was -$9.97M.
- BIONIK LABORATORIES CORP. operating income (loss) for fiscal 2021 was -$13.34M.
- BIONIK LABORATORIES CORP. operating income (loss) for fiscal 2020 was -$25.09M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 24 month |
|---|---|---|---|---|---|
| 2023-03-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$2.34M derived: sum of 2 quarters · filed 2023-06-21 | -$3.45M derived: sum of 3 quarters · filed 2023-06-21 | -$4.83M 10-K · filed 2023-06-21 | |
| 2022-12-31 | -$1.04M 10-Q · filed 2023-02-08 | -$2.15M derived: sum of 2 quarters · filed 2023-02-08 | -$3.53M 10-Q · filed 2023-02-08 | -$4.93M derived: sum of 4 quarters · filed 2023-06-21 | |
| 2022-09-30 | -$1.11M 10-Q · filed 2022-11-09 | -$2.48M 10-Q · filed 2022-11-09 | -$3.89M derived: sum of 3 quarters · filed 2023-06-21 | -$10.61M derived: sum of 4 quarters · filed 2023-06-21 | |
| 2022-06-30 | -$1.37M 10-Q · filed 2022-08-10 | -$2.77M derived: sum of 2 quarters · filed 2023-06-21 | -$9.50M derived: sum of 3 quarters · filed 2023-06-21 | -$10.54M derived: sum of 4 quarters · filed 2023-06-21 | |
| 2022-03-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$8.13M derived: sum of 2 quarters · filed 2023-06-21 | -$9.17M derived: sum of 3 quarters · filed 2023-06-21 | -$9.97M 10-K · filed 2023-06-21 | |
| 2021-12-31 | -$6.73M 10-Q · filed 2023-02-08 | -$7.77M derived: sum of 2 quarters · filed 2023-02-08 | -$8.57M 10-Q · filed 2023-02-08 | -$9.54M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-09-30 | -$1.04M 10-Q · filed 2022-11-09 | -$1.84M 10-Q · filed 2022-11-09 | -$2.81M derived: sum of 3 quarters · filed 2022-11-09 | -$11.68M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$801.88K 10-Q · filed 2022-08-10 | -$1.77M derived: sum of 2 quarters · filed 2022-08-10 | -$10.64M derived: sum of 3 quarters · filed 2022-08-10 | -$12.18M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$966.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-09 | -$9.84M derived: sum of 2 quarters · filed 2022-06-09 | -$11.38M derived: sum of 3 quarters · filed 2022-06-09 | -$13.34M 10-K · filed 2022-06-09 | |
| 2020-12-31 | -$8.87M 10-Q · filed 2022-02-09 | -$10.41M derived: sum of 2 quarters · filed 2022-02-09 | -$12.37M 10-Q · filed 2022-02-09 | -$28.94M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | -$1.54M 10-Q · filed 2021-11-10 | -$3.50M 10-Q · filed 2021-11-10 | -$20.07M derived: sum of 3 quarters · filed 2021-11-10 | -$23.20M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.96M 10-Q · filed 2021-08-12 | -$18.53M derived: sum of 2 quarters · filed 2021-08-12 | -$21.65M derived: sum of 3 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$16.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-24 | -$19.70M derived: sum of 2 quarters · filed 2021-06-24 | -$25.09M 10-K · filed 2021-06-24 | ||
| 2019-12-31 | -$3.13M 10-Q · filed 2021-02-11 | -$8.52M 10-Q · filed 2021-02-11 | |||
| 2015-09-30 | -$1.18M 10-Q · filed 2015-11-12 | -$3.60M derived: sum of 2 quarters · filed 2015-11-12 | -$4.83M 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | -$2.42M 10-Q · filed 2015-08-14 | -$3.67M 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | -$1.25M 10-Q · filed 2015-05-20 | ||||
| 2014-12-31 | -$2.46M 10-KT · filed 2015-05-27 | ||||
| 2014-09-30 | -$1.17M 10-Q · filed 2015-11-12 | -$1.80M derived: sum of 2 quarters · filed 2015-11-12 | -$1.93M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$627.57K 10-Q · filed 2015-08-14 | -$787.10K 10-Q · filed 2015-08-14 | |||
| 2014-03-31 | -$82.48K 10-Q · filed 2015-05-20 | -$1.45M 10-KT · filed 2015-05-27 | |||
| 2013-12-31 | -$1.43M 10-KT · filed 2015-05-27 | ||||
| 2013-03-31 | -$937.06K 10-KT · filed 2015-05-27 | ||||
| 2011-12-31 | -$4.48K 10-K · filed 2012-04-11 | -$12.54K 10-K · filed 2012-04-11 | |||
| 2010-12-31 | -$8.07K 10-K · filed 2012-04-11 |